To sum up, the study emphasizes that the RNA m6A methylation factor, i.e., WTAP, possesses an important function in DLBCL and will support the exploration of novel therapeutic approaches for DLBCL. This evidence concerns the gene WTAP and diffuse large B-cell lymphoma.